Morrisville, N.C., September 2, 2021 — Premier Research has appointed Jennifer Nezzer, M.S., as Vice President of Biometrics. Nezzer, an industry-recognized expert in biostatistics with more than 25 years of global clinical research experience, will head Premier’s integrated Biostatistics and Medical Writing operational departments. Premier Research is a leading provider of clinical research, product development, and consulting services to the biotech, specialty pharma, and medical device sectors.
“Adaptive design studies and trials for advanced therapies are increasing, and these complex, challenging investigations require the most up-to-date biostatistical methods,” says Krista Armstrong, Ph.D., Premier Research’s Senior Vice President, Clinical Development Services. “Jennifer will help us bring the latest statistical processes to the table for our clients with her experience managing the statistical components of Phase 1 through Phase 4 trials for both traditional and adaptive study designs in multiple therapeutic areas.”
Nezzer will serve as a statistical advisor with contributions specifically in protocol design, clinical study review, and communications with regulatory authorities, including developing and implementing Premier’s new global standards for quality systems, processes, and procedures. She has managed biostatistical aspects of multiple submissions to the EMA and FDA, including developing Integrated Summary of Safety/Integrated Summary of Effectiveness and Electronic Common Technical Document submission-ready documents.
Nezzer earned a B.A. in statistics from Kansas State University and an M.S. in statistics from New Mexico State University. She is a member of the American Statistical Association.
Click here for more information on how Premier Research’s Biostatistics and Medical Writing departments work together to facilitate high-quality data outcomes for sponsors.
About Premier Research
Premier Research, a clinical research, product development, and consulting company, is dedicated to helping biotech, specialty pharma, and device innovators transform life-changing ideas and breakthrough science into new medical treatments.
As a global company, Premier Research specializes in the use of innovative technologies for smart study design and trial management to deliver clean, conclusive data to sponsors.
Whether it’s developing product lifecycle strategies, reducing clinical development cycle times, securing access to patients, navigating global regulations, maximizing the impact of limited rare disease data, or providing expertise in specific therapeutic areas, Premier Research is committed to helping its customers answer the unmet needs of patients across a broad range of medical conditions. Visit premierresearch.cn.